Concentrations of amyloid β protein in cerebrospinal fluid of patients with alzheimer's disease
Authors:
- 1 February 1995
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 37 (2) , 277-279
Abstract
Deposition of fibrillar amyloid β protein (Aβ) is increased in brains of patients with Alzheimer's disease. Concentrations of Aβ were measured in cerebrospinal fluid with an enzyme‐linked immunosorbent assay in 10 neurological patients free from neurodegenerative disease, 28 patients with Parkinson's disease, and 18 patients with probable Alzheimer's disease. Levels of Aβ in cerebrospinal fluid were not significantly different among these groups. This observation suggests that concentrations of soluble Aβ in cerebrospinal fluid as measured in this study do not reflect the amount of fibrillar, aggregated Aβ in the brain of patients with Alzheimer's disease.Keywords
This publication has 17 references indexed in Scilit:
- Concentrations of amyloid-β protein in cerebrospinal fluid increase with age in patients free from neurodegenerative diseaseNeuroscience Letters, 1994
- Genetics and molecular advances in Alzheimer's diseaseTrends in Neurosciences, 1993
- Release of Excess Amyloid β Protein from a Mutant Amyloid β Protein PrecursorScience, 1993
- Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein productionNature, 1992
- Production of the Alzheimer Amyloid β Protein by Normal Proteolytic ProcessingScience, 1992
- Isolation and quantification of soluble Alzheimer's β-peptide from biological fluidsNature, 1992
- Amyloid β-peptide is produced by cultured cells during normal metabolismNature, 1992
- Clinically Diagnosed Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1992
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984